Covid-19 roundup: Catalent lends vaccine production capacity to AstraZeneca/Oxford for hundreds of millions doses
Catalent’s growth play in Italy a year ago is paying off amid a dramatic explosion in demand for space to produce Covid-19 vaccines. In …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
